Css LLC Ionis Pharmaceuticals Inc Put Options Transaction History

Css LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $368,145 - $481,770	10,100 Added 202.0%	15,100 $719,000
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $210,150 - $267,750	5,000 New	5,000 $216,000
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $238,935 - $311,355	-5,100 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $5.08 Million - $7.73 Million	-122,000 Reduced 95.99%	5,100 $241,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $5.92 Million - $7.17 Million	109,900 Added 638.95%	127,100 $7.68 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $755,968 - $923,520	12,800 Added 290.91%	17,200 $1.03 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $1.38 Million - $2.11 Million	-26,000 Reduced 85.53%	4,400 $357,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $686,080 - $859,200	16,000 Added 111.11%	30,400 $1.57 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $267,498 - $334,620	-6,600 Reduced 31.43%	14,400 $601,000
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $573,040 - $715,650	13,000 Added 162.5%	21,000 $926,000
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $364,480 - $476,560	8,000	8,000 $406,000

386

125M

2.19M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.46B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.